ECO 2026 12 - 15 May 2026

Characteristics, Attitudes and Experiences of Individuals Using Injectable Semaglutide for Obesity Management: An Interim Analysis of the OUTSTEP 1 Study

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress oral presentation
GLP-1 RA
Semaglutide
RWE HEOR